175 related articles for article (PubMed ID: 29113666)
1. Predictive biomarkers for response of esophageal cancer to chemo(radio)therapy: A systematic review and meta-analysis.
Li Y; Huang HC; Chen LQ; Xu LY; Li EM; Zhang JJ
Surg Oncol; 2017 Dec; 26(4):460-472. PubMed ID: 29113666
[TBL] [Abstract][Full Text] [Related]
2. Molecular Markers for the Prediction of Minor Response to Neoadjuvant Chemoradiation in Esophageal Cancer: Results of the Prospective Cologne Esophageal Response Prediction (CERP) Study.
Bollschweiler E; Hölscher AH; Herbold T; Metzger R; Alakus H; Schmidt H; Drebber U; Warnecke-Eberz U
Ann Surg; 2016 Nov; 264(5):839-846. PubMed ID: 27741011
[TBL] [Abstract][Full Text] [Related]
3. [Salvage surgery in esophageal cancer : Feasibility in patients after definitive radiochemotherapy (> 50 Gy)].
Schmidt T; Sisic L; Sterzing F; Haag GM; Kunzmann R; Grenacher L; Weichert W; Jäger D; Büchler MW; Ott K
Chirurg; 2015 Oct; 86(10):955-62. PubMed ID: 25715974
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis.
Walter F; Böckle D; Schmidt-Hegemann NS; Köpple R; Gerum S; Boeck S; Angele M; Belka C; Roeder F
Radiat Oncol; 2018 May; 13(1):93. PubMed ID: 29769143
[TBL] [Abstract][Full Text] [Related]
5. Correlation of p53 status with the response to chemotherapy-based treatment in esophageal cancer: a meta-analysis.
Zhang SS; Huang QY; Yang H; Xie X; Luo KJ; Wen J; Cai XL; Yang F; Hu Y; Fu JH
Ann Surg Oncol; 2013 Jul; 20(7):2419-27. PubMed ID: 23515910
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.
Findlay JM; Middleton MR; Tomlinson I
Ann Oncol; 2015 Apr; 26(4):624-644. PubMed ID: 25214541
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.
Chen M; Huang J; Zhu Z; Zhang J; Li K
BMC Cancer; 2013 Nov; 13():539. PubMed ID: 24206575
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of the red cell distribution width in esophageal cancer patients: A systematic review and meta-analysis.
Xu WY; Yang XB; Wang WQ; Bai Y; Long JY; Lin JZ; Xiong JP; Zheng YC; He XD; Zhao HT; Sang XT
World J Gastroenterol; 2018 May; 24(19):2120-2129. PubMed ID: 29785080
[TBL] [Abstract][Full Text] [Related]
9. P53 and SOX2 Protein Expression Predicts Esophageal Adenocarcinoma in Response to Neoadjuvant Chemoradiotherapy.
van Olphen SH; Biermann K; Shapiro J; Wijnhoven BP; Toxopeus EL; van der Gaast A; Stoop HA; van Lanschot JJ; Spaander MC; Bruno MJ; Looijenga LH
Ann Surg; 2017 Feb; 265(2):347-355. PubMed ID: 28059963
[TBL] [Abstract][Full Text] [Related]
10. [Neoadjuvant chemoradiotherapy combined with operation vs. operation alone for resectable esophageal cancer: Meta-analysis on randomized controlled trials].
Duan X; Yu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jul; 20(7):809-815. PubMed ID: 28722096
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of p53 expression in patients with esophageal cancer: a meta-analysis.
Wang L; Yu X; Li J; Zhang Z; Hou J; Li F
BMC Cancer; 2016 Jul; 16():373. PubMed ID: 27370310
[TBL] [Abstract][Full Text] [Related]
12. Concurrent neoadjuvant chemoradiotherapy could improve survival outcomes for patients with esophageal cancer: a meta-analysis based on random clinical trials.
Liu B; Bo Y; Wang K; Liu Y; Tang X; Zhao Y; Zhao E; Yuan L
Oncotarget; 2017 Mar; 8(12):20410-20417. PubMed ID: 28099899
[TBL] [Abstract][Full Text] [Related]
13. The gap before real clinical application of imaging-based machine-learning and radiomic models for chemoradiation outcome prediction in esophageal cancer: a systematic review and meta-analysis.
Yang Z; Gong J; Li J; Sun H; Pan Y; Zhao L
Int J Surg; 2023 Aug; 109(8):2451-2466. PubMed ID: 37463039
[TBL] [Abstract][Full Text] [Related]
14. Prolonged interval between neoadjuvant chemoradiotherapy and esophagectomy does not benefit the outcome in esophageal cancer: a systematic review and meta-analysis.
Tie H; He F; Shen J; Zhang B; Ye M; Chen B; Wu Q
Dis Esophagus; 2018 Jan; 31(1):1-9. PubMed ID: 29087451
[TBL] [Abstract][Full Text] [Related]
15. Radio(chemo)therapy for locally advanced squamous cell carcinoma of the esophagus: long-term outcome.
Ordu AD; Nieder C; Geinitz H; Kup PG; Deymann LF; Scherer V; Combs SE; Fakhrian K
Strahlenther Onkol; 2015 Feb; 191(2):153-60. PubMed ID: 25404062
[TBL] [Abstract][Full Text] [Related]
16. Molecular factors and criteria for predicting the response to neoadjuvant treatment in patients with esophageal squamous cell carcinoma (ESCC) -- responder/non-responder.
Predescu D; Gheorghe M; Boeriu M; Constantin A; Iosif C; Anghel R; Constantinoiu S
Chirurgia (Bucur); 2012; 107(5):583-90. PubMed ID: 23116831
[TBL] [Abstract][Full Text] [Related]
17. Effect of preoperative radio(chemo)therapy on long-term functional outcome in rectal cancer patients: a systematic review and meta-analysis.
Loos M; Quentmeier P; Schuster T; Nitsche U; Gertler R; Keerl A; Kocher T; Friess H; Rosenberg R
Ann Surg Oncol; 2013 Jun; 20(6):1816-28. PubMed ID: 23269466
[TBL] [Abstract][Full Text] [Related]
18. CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy.
Honing J; Pavlov KV; Mul VE; Karrenbeld A; Meijer C; Faiz Z; Smit JK; Hospers GA; Burgerhof JG; Kruyt FA; Kleibeuker JH; Plukker JT
Radiother Oncol; 2015 Oct; 117(1):152-8. PubMed ID: 26364884
[TBL] [Abstract][Full Text] [Related]
19. Identification of serum biomarkers of chemoradiosensitivity in esophageal cancer via the targeted metabolomics approach.
Fujigaki S; Nishiumi S; Kobayashi T; Suzuki M; Iemoto T; Kojima T; Ito Y; Daiko H; Kato K; Shouji H; Honda K; Azuma T; Yoshida M
Biomark Med; 2018 Aug; 12(8):827-840. PubMed ID: 30043633
[TBL] [Abstract][Full Text] [Related]
20. Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: A meta-analysis of 17 published studies.
Tomasello G; Petrelli F; Ghidini M; Pezzica E; Passalacqua R; Steccanella F; Turati L; Sgroi G; Barni S
Eur J Surg Oncol; 2017 Sep; 43(9):1607-1616. PubMed ID: 28347525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]